Amazon identified as key client ending agreement with Progyny – report
- Amazon (AMZN) has elected not to continue with Progyny (NASDAQ:PGNY) as the company’s fertility benefits provider for employees starting Jan. 1, 2025, and is switching to Maven.
- Maven has alsready been working with Amazon by providing virtual “family-building care,” according to a report in STAT.
- After trading hours on Sept. 18, Progyny disclosed it was losing a “significant client” at the start of the new year, noting the client was responsible for 13% of its 2023 revenue. The following day, the stock closed down ~33%.